Literature DB >> 19585357

Endogenous Klebsiella endophthalmitis associated with Klebsiella pneumoniae pneumonia.

Kuan-Jen Chen1, Yih-Shiou Hwang, Yen-Po Chen, Chi-Chun Lai, Tun-Lu Chen, Nan-Kai Wang.   

Abstract

PURPOSE: To investigate the management, bacterial strains, antibiotic sensitivities, and visual outcomes in patients with Klebsiella pneumoniae pneumonia and endogenous Klebsiella endophthalmitis.
METHODS: Data were collected for treatments, antibiotic sensitivity patterns, and final visual outcomes.
RESULTS: The study included 10 eyes of 9 patients with a median age of 42 years (range, 0-86 years). Diabetes mellitus was the most common comorbid risk factor (n = 5, 56%). Nine eyes (90%) were treated with intravitreal antibiotics, and one with pars plana vitrectomy and intravitreal antibiotics. One eye achieved a favorable visual acuity of 20/20; however, 6 eyes developed vision of no light perception, including 2 of evisceration. Two nosocomial K. pneumoniae isolates were extended-spectrum-beta-lactamase-producing strains, which demonstrated the resistance to amikacin and ceftazidime.
CONCLUSIONS: Ophthalmologists and physicians should be aware of Klebsiella pneumonia as a possible cause of endogenous endophthalmitis, and endogenous Klebsiella endophthalmitis usually causes poor visual outcomes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19585357     DOI: 10.1080/09273940902752250

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.070


  6 in total

1.  [Endophthalmitis].

Authors:  Thomas Neß
Journal:  Ophthalmologe       Date:  2018-08       Impact factor: 1.059

2.  Clinical review of endogenous endophthalmitis in Korea: a 14-year review of culture positive cases of two large hospitals.

Authors:  Kyu Sik Chung; Young Keun Kim; Young Goo Song; Chang Oh Kim; Sang Hoon Han; Bum Sik Chin; Nam Su Gu; Su Jin Jeong; Ji-Hyeon Baek; Jun Yong Choi; Hyo Youl Kim; June Myung Kim
Journal:  Yonsei Med J       Date:  2011-07       Impact factor: 2.759

3.  Drug delivery to the posterior segment of the eye for pharmacologic therapy.

Authors:  Shalin S Shah; Lori Vidal Denham; Jasmine R Elison; Partha S Bhattacharjee; Christian Clement; Tashfin Huq; James M Hill
Journal:  Expert Rev Ophthalmol       Date:  2010-02-01

4.  Endophthalmitis: A review of recent trends.

Authors:  Janice R Safneck
Journal:  Saudi J Ophthalmol       Date:  2012-03-03

5.  Infection Sources and Klebsiella pneumoniae Antibiotic Susceptibilities in Endogenous Klebsiella Endophthalmitis.

Authors:  Kuan-Jen Chen; Yen-Po Chen; Yi-Hsing Chen; Laura Liu; Nan-Kai Wang; An-Ning Chao; Wei-Chi Wu; Yih-Shiou Hwang; Hung-Da Chou; Eugene Yu-Chuan Kang; Yen-Ting Chen; Ming-Hui Sun; Chi-Chun Lai
Journal:  Antibiotics (Basel)       Date:  2022-06-27

6.  Susceptibility of bacterial endophthalmitis isolates to vancomycin, ceftazidime, and amikacin.

Authors:  Kuan-Jen Chen; Ming-Hui Sun; Chiun-Ho Hou; Hung-Chi Chen; Yen-Po Chen; Nan-Kai Wang; Laura Liu; Wei-Chi Wu; Hung-Da Chou; Eugene Yu-Chuan Kang; Chi-Chun Lai
Journal:  Sci Rep       Date:  2021-08-05       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.